Trial Profile
Phase I Single Dose Safety and Pharmacokinetic Study of Bowman Birk Inhibitor Concentrate, Delivered as an Orange Juice Suspension to Healthy Male Volunteers Between 18 and 65 Years of Age.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Bowman-Birk inhibitor concentrate (Primary)
- Indications Cancer
- Focus Adverse reactions
- 28 Aug 2007 Status change from recruiting to completed.
- 11 Sep 2006 New trial record.